|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive ,Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
A myc tag is a polypeptide protein tag derived from the c-myc gene product that can be added to a protein using recombinant DNA technology. It can be used for affinity chromatography, then used to separate recombinant, overexpressed protein from wild type protein expressed by the host organism. It can also be used in the isolation of protein complexes with multiple subunits.
A myc tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a myc-tag allows one to follow the protein with an antibody against the Myc epitope. Examples are cellular localization studies by immunofluorescence or detection by Western blotting.
The peptide sequence of the myc-tag is: N-EQKLISEEDL-C (1202 Da). It can be fused to the C-terminus and the N-terminus of a protein. It is advisable not to fuse the tag directly behind the signal peptide of a secretory protein, since it can interfere with translocation into the secretory pathway.
|小鼠 PLA2G1B 基因全長cDNA ORF克隆 (表達載體), C-GFPSpark 標籤||MG50329-ACG|
|小鼠 PLA2G1B 基因全長cDNA ORF克隆 (表達載體), C-OFPSpark 標籤||MG50329-ACR|
|小鼠 PLA2G1B 基因全長cDNA ORF克隆 (表達載體), C-Flag 標籤||MG50329-CF|
|小鼠 PLA2G1B 基因全長cDNA ORF克隆 (表達載體), C-His 標籤||MG50329-CH|
|小鼠 PLA2G1B 基因全長cDNA ORF克隆 (表達載體), C-Myc 標籤||MG50329-CM|
|小鼠 PLA2G1B 基因全長cDNA ORF克隆 (表達載體), C-HA 標籤||MG50329-CY|
|小鼠 PLA2G1B 基因全長cDNA ORF(克隆載體)||MG50329-M|
|小鼠 PLA2G1B 基因全長cDNA ORF克隆 (表達載體), N-Flag 標籤||MG50329-NF|
|小鼠 PLA2G1B 基因全長cDNA ORF克隆 (表達載體), N-His 標籤||MG50329-NH|
|小鼠 PLA2G1B 基因全長cDNA ORF克隆 (表達載體), N-Myc 標籤||MG50329-NM|
|小鼠 PLA2G1B 基因全長cDNA ORF克隆 (表達載體), N-HA 標籤||MG50329-NY|
|小鼠 PLA2G1B 基因全長cDNA ORF克隆 (表達載體)||MG50329-UT|
Mouse phospholipase A2, also known as Phosphatidylcholine 2-acylhydrolase 1B, Group IB phospholipase A2, PLA2 and PLA2G1B, is a secreted protein which belongs to the phospholipase A2 family. Phospholipase A2 / PLA2G1B catalyzes the release of fatty acids from glycero-3-phosphocholines. The best known varieties are the digestive enzymes secreted as zymogens by the pancreas of mammals. Sequences of pancreatic Phospholipase A2 / PLA2G1B enzymes from a variety of mammals have been reported. One striking feature of these enzymes is their close homology to venom phospholipases of snakes. Other forms of Phospholipase A2 / PLA2G1B have been isolated from brain, liver, lung, spleen, intestine, macrophages, leukocytes, erythrocytes, inflammatory exudates, chondrocytes, and platelets. Mice lacking in Phospholipase A2 / PLA2G1B are resistant to obesity and diabetes induced by feeding a diabetogenic high-fat/high-carbohydrate diet. Oral supplementation of a diabetogenic diet with the PLA2G1B inhibitor methyl indoxam effectively suppresses diet-induced obesity and diabetes. PLA2G1B inhibition may be a potentially effective oral therapeutic option for treatment of obesity and diabetes.